¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"pedigree pattern of autosomal dominant trait"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • dominant character
    ¿ì¼ºÇüÁú
  • dominant complement
    ¿ì¼ºº¸Ã¼
  • dominant eye
    ¿ì¼¼¾È
  • dominant gene
    ¿ì¼ºÀ¯ÀüÀÚ
  • dominant hemisphere
    ¿ì¼º´ë³ú¹Ý±¸
  • dominant inheritance
    ¿ì¼ºÀ¯Àü
  • dominant mutation
    ¿ì¼ºµ¹¿¬º¯ÀÌ
  • dominant receptor
    ¿ì¼º¼ö¿ëü
  • homozygous dominant
    µ¿Á¾Á¢Çտ켺-
  • incompletely dominant
    ºÒ¿ÏÀü¿ì¼º-
  • sex-linked dominant inheritance
    ¼º¿¬°ü¿ì¼ºÀ¯Àü
  • X-linked dominant inheritance
    X¿¬°ü¿ì¼ºÀ¯Àü
  • complete interference pattern
    ¿ÏÀü°£¼·¾ç»ó
  • complete recruitment pattern
    ¿ÏÀüÁ¡Áõ¾ç»ó
  • complex echo pattern
    º¹Çո޾Ƹ®¸ð¾ç, º¹ÇÕ¿¡ÄÚ¾ç»ó
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • trait
    ¼ÒÁú, ¼ºÇâ
  • dominant character
    ¿ì¼ºÇüÁú, Áö¹èÀûÇüÁú
  • dominant complement
    ¿ì¼ºµµ¿òü
  • dominant
    ¿ì¼º-, ¿ì¼¼-, ¿ìÀ§-, ¿ì¼º
  • dominant eye
    ¿ì¼¼¾È
  • dominant gene
    ¿ì¼ºÀ¯ÀüÀÚ
  • dominant hemisphere
    ¿ì¼º´ë³ú¹Ý±¸
  • dominant inheritance
    ¿ì¼ºÀ¯Àü
  • dominant mutation
    ¿ì¼ºµ¹¿¬º¯ÀÌ
  • dominant receptor
    ¿ì¼º¼ö¿ëü
  • dominant species
    ¿ì¼ºÁ¾
  • homozygous dominant
    µ¿Á¾Á¢Çտ켺
  • sex-linked dominant inheritance
    ¼º¿¬°ü¿ì¼ºÀ¯Àü
  • female pattern baldness
    ¿©¼ºÇü´ë¸Ó¸®
  • male pattern baldness
    ³²¼ºÇü´ë¸Ó¸®
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • hemoglobin D trait
    Çì¸ð±Û·ÎÁø D ¼ÒÁú<Ư¼º
  • hemoglobin E trait
    Çì¸ð±Û·Îºó E ¼ÒÁú<Ư¼º
  • hereditary trait
    À¯Àü¼ÒÁú(ë¶îîáÈòõ).
  • personality trait
    ÀÎ°ÝÆ¯¼º(¡­÷åàõ).
  • recessive trait
    ¿­¼ºÇüÁú(¡­û¡òõ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • recessive trait
    ¿­¼ºÇüÁú(¡­û¡òõ).
  • sex linked trait
    ¹Ý¼ºÇüÁú.
  • sickle cell trait
    ÀûÇ÷±¸°â»óÇü¼º°æÇâ
  • sickle cell trait
    ÀûÇ÷±¸°â»óÇü¼º°æÇâ(îåúìϹÌÇßÒû¡à÷ÌËú¾).
  • sickle cell trait
    ÀûÇ÷±¸°â»óÇü¼º°æÇâ(îåúìϹÌÇßÒû¡à÷ÌËú¾)
  • thalassemia trait
    ÁöÁßÇØºóÇ÷¼ÒÁú(áÈòõ)
  • thalassemia trait
    #NAME?
  • trait(s)
    Ư¼º(÷åàõ), ¼ÒÁú(áÈòõ).
  • trait-dependent
    Ư¼º-ÀÇÁ¸Àû(÷åàõëîðíîÜ).
  • autosomal
    »ó¿°»öü¼º(ßÈæøßäô÷àõ)
  • autosomal
    »ó¿°»öü(ÀÇ).
  • autosomal abnormality
    »ó¿°»öüÀÌ»ó(¡­æøßäô÷ì¶ßÈ).
  • autosomal gene
    º¸Åë¿°»öüÀ¯ÀüÀÚ
  • autosomal inheritance
    »ó¿°»öü¼º À¯Àü.
  • autosomal recessive
    »ó¿°»öü¿­¼º(¡­æøßäô÷æëàõ)ÀÇ.
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • mucosal pattern
    Àḷ»ó
  • nodular pattern
    ¼Ò°áÀý¾ç»ó
  • pattern
    ¸ð¾ç, ¾ç½Ä, ÆÐÅÏ
  • pattern recognition
    ÆÐÅÏÀνÄ, ¸ð¾çÀνÄ
  • string of beads pattern
    ¿°ÁÖ ¸ð¾ç
  • target pattern
    °ú³á¾ç»ó
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
ADPKD autosomal dominant polycystic kidney disease
ADVIRC autosomal dominant vitreo-retinochoroidopathy
MEN Multiple Endocrine Neoplasia
  ; AD Trait
  1. MEN Type I(= Wermer Syndro...
PBT Paul-Bunnell test; phenacetin breath test; piebald trait; profile-based therapy
PTD percutaneous transluminal dilatation; permanent total disability; personality trait disorder; preter...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CADASIL Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leucoencephalopathy
APM Affected pedigree member
QTL Aquantitative trait locus
QTL Quantitative Trait Loci
QTLs Quantitative Trait Loci
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • dominant
    ¿ì¼º, ¿ì¼ºÀÇ
    1. ¿ì¼¼ ¶Ç´Â Áö¹èÀû ¿µÇâÀ» ¹ßÈÖÇÏ´Â. À¯ÀüÇп¡¼­´Â ÇÑ ½ÖÀÌ »óµ¿¿°»öü ÇÑ Âʸ¸À¸·Î ¿î¹ÝµÇ¾îµµ ¹ßÇö °¡´ÉÇÑ. 2. ¿ì¼º ÇüÁú. ¿ì¼º ¼ÒÁú.
  • dominant character
    ¿ì¼º ÇüÁú, Áö¹èÀû Ư¼º
  • dominant cystoid macular dystrophy
    ¿ì¼º ³¶Æ÷ Ȳ¹Ý ÀÌ¿µ¾çÁõ
  • dominant exudative vitreoretinopathy
    ¿ì¼º »ïÃâÀ¯¸®Ã¼ ¸Á¸·º¯Áõ
  • dominant gene
    ¿ì¼º À¯ÀüÀÚ
  • dominant inheritance
    ¿ì¼º À¯Àü
  • dominant receptor
    ¿ì¼º ¼ö¿ëü
  • banding pattern
    ´ë»ó ±¸Á¶
  • basic pattern
    ±âº»Çü
  • beamlike pattern
    ±¤¼± °°Àº ÆÐÅÏ
  • blood flow pattern
    Ç÷·ù ¾ç»ó
  • butterfly pattern
    ³ªºñ ÇüÅÂ, ³ªºñÇü
  • dermal pattern
    ÁøÇÇÇü
  • dietary pattern
    ½ÄÀÌ ¾ç½Ä
  • dolicofacial skeletal pattern
    Àå¾È¸ðÀÇ °ñ°Ý ÇüÅÂ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
dominant eye The eye that is customarily used for monocular tasks.
Synonym: master eye.
(05 Mar 2000)
dominant frequency The frequency occurring most often in an electroencephalogram.
(05 Mar 2000)
dominant gene dominance of traits
dominant hemisphere That cerebral hemisphere containing the representation of speech and controlling the arm and leg used preferentially in skilled movements; usually the left hemisphere.
(05 Mar 2000)
dominant idea An idea that governs all one's actions and thoughts.
(05 Mar 2000)
dominant inheritance dominance of traits
dominant oncogene <genetics, molecular biology, oncology> A gene that stimulates cell proliferation and can drastically increase the risk of cancer development when present in a single copy.
(09 Oct 1997)
dominant species <biology, ecology, zoology> For each stratum, dominant species are those that, when ranked in descending rank order and cumulatively totaled, immediately exceed 50 percent of the total dominance measure, plus any additional species comprising 20 percent or more of the total dominance measure for the stratum.
(09 Oct 1997)
Bombay trait A rare recessive trait at a locus that ordinarily manufactures H substance, the precursor from which the A and B phenotypes are elaborated; the mutant causes failure to produce H substance and no matter what the genotype at the ABO locus, the phenotype is O. The Bombay phenomenon is epistatic to the ABO locus.
Origin: Bombay, India, where first reported
(05 Mar 2000)
galtonian trait A quantitative genetic trait due to contributions from many more of less equally important loci that resembles a continuous trait.
(05 Mar 2000)
recessive trait See: dominance of traits.
(05 Mar 2000)
marker trait A trait that may be of little importance in itself but which by association, linkage, or other means facilitates the detection, anticipation, or understanding of a disease or (for genetic diseases) the localization of the causative gene on the karyotype.
(05 Mar 2000)
categorical trait <genetics> A feature that can conveniently and effectively be analyzed by sorting into classes either because there is no satisfactory way of measuring it (as with blood groups) or because it falls into natural classes so that the variation among classes far exceeds that within classes (e.g., the phenotypic effects of many enzyme polymorphisms); existence of categories suggests but does not prove the operation of a major, simple, underlying cause.
Synonym: qualitative trait.
(05 Mar 2000)
penetrant trait A trait that in the appropriate genotypes is phenotypically manifest; strictly, it is the trait that is penetrant, not the gene.
See: penetrance.
(05 Mar 2000)
mendelian trait A categorical trait that segregates in accordance with a single-locus genetic system.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • pattern bombing
    ÀÏÁ¦ Æø°Ý
  • pattern glass
    Àå½Ä ¹«´Ì°¡ µç À¯¸® Á¦Ç°
  • pattern practice
    ¹®Çü ¿¬½À
  • pattern recognitiono
    ÆÐÅÏ ÀνÄ
  • pattern room(shop)
    (ÁÖ¹° °øÀåÀÇ)¸ñÇü Á¦ÀÛºÎ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á